Atlantic Coastal Acquisition Corp. II (ACABW) Competitors $0.0034 0.00 (0.00%) As of 05/22/2026 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsTrendsBuy This Stock ACABW vs. AIMDW, ALVOW, ARAV, BFRIW, and CELUWShould you buy Atlantic Coastal Acquisition Corp. II stock or one of its competitors? MarketBeat compares Atlantic Coastal Acquisition Corp. II with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Atlantic Coastal Acquisition Corp. II include Ainos (AIMDW), Alvotech (ALVOW), Aravive (ARAV), Biofrontera (BFRIW), and Celularity (CELUW). These companies are all part of the "pharmaceutical products" industry. ACABW vs. AIMDWACABW vs. ALVOWACABW vs. ARAVACABW vs. BFRIWACABW vs. CELUWHow does Atlantic Coastal Acquisition Corp. II compare to Ainos?Ainos (NASDAQ:AIMDW) and Atlantic Coastal Acquisition Corp. II (NASDAQ:ACABW) are both pharmaceutical products companies, but which is the superior business? We will compare the two companies based on the strength of their valuation, dividends, risk, media sentiment, institutional ownership, earnings, profitability and analyst recommendations. Is AIMDW or ACABW more profitable? Company Net Margins Return on Equity Return on Assets AinosN/A N/A N/A Atlantic Coastal Acquisition Corp. II N/A N/A N/A Does the media favor AIMDW or ACABW? In the previous week, Ainos' average media sentiment score of 0.00 equaled Atlantic Coastal Acquisition Corp. II'saverage media sentiment score. Company Overall Sentiment Ainos Neutral Atlantic Coastal Acquisition Corp. II Neutral Which has better earnings & valuation, AIMDW or ACABW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAinos$18.11KN/AN/AN/AN/AAtlantic Coastal Acquisition Corp. IIN/AN/AN/AN/AN/A SummaryAinos beats Atlantic Coastal Acquisition Corp. II on 1 of the 1 factors compared between the two stocks.How does Atlantic Coastal Acquisition Corp. II compare to Alvotech?Alvotech (NASDAQ:ALVOW) and Atlantic Coastal Acquisition Corp. II (NASDAQ:ACABW) are both pharmaceutical products companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, profitability, valuation, analyst recommendations, dividends, media sentiment, earnings and risk. Is ALVOW or ACABW more profitable? Company Net Margins Return on Equity Return on Assets AlvotechN/A N/A N/A Atlantic Coastal Acquisition Corp. II N/A N/A N/A Does the media refer more to ALVOW or ACABW? In the previous week, Alvotech's average media sentiment score of 0.00 equaled Atlantic Coastal Acquisition Corp. II'saverage media sentiment score. Company Overall Sentiment Alvotech Neutral Atlantic Coastal Acquisition Corp. II Neutral Which has better earnings and valuation, ALVOW or ACABW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAlvotech$586.32MN/AN/AN/AN/AAtlantic Coastal Acquisition Corp. IIN/AN/AN/AN/AN/A SummaryAlvotech beats Atlantic Coastal Acquisition Corp. II on 1 of the 1 factors compared between the two stocks.How does Atlantic Coastal Acquisition Corp. II compare to Aravive?Aravive (NASDAQ:ARAV) and Atlantic Coastal Acquisition Corp. II (NASDAQ:ACABW) are both pharmaceutical products companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, dividends, media sentiment, profitability, analyst recommendations, valuation, earnings and risk. Do institutionals & insiders have more ownership in ARAV or ACABW? 35.8% of Aravive shares are owned by institutional investors. 60.4% of Aravive shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Is ARAV or ACABW more profitable? Company Net Margins Return on Equity Return on Assets AraviveN/A N/A N/A Atlantic Coastal Acquisition Corp. II N/A N/A N/A Does the media refer more to ARAV or ACABW? In the previous week, Aravive's average media sentiment score of 0.00 equaled Atlantic Coastal Acquisition Corp. II'saverage media sentiment score. Company Overall Sentiment Aravive Neutral Atlantic Coastal Acquisition Corp. II Neutral Which has preferable earnings and valuation, ARAV or ACABW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAraviveN/AN/AN/A-$0.90N/AAtlantic Coastal Acquisition Corp. IIN/AN/AN/AN/AN/A SummaryAravive beats Atlantic Coastal Acquisition Corp. II on 2 of the 2 factors compared between the two stocks.How does Atlantic Coastal Acquisition Corp. II compare to Biofrontera?Atlantic Coastal Acquisition Corp. II (NASDAQ:ACABW) and Biofrontera (NASDAQ:BFRIW) are both pharmaceutical products companies, but which is the superior investment? We will contrast the two companies based on the strength of their media sentiment, risk, valuation, profitability, analyst recommendations, dividends, earnings and institutional ownership. Is ACABW or BFRIW more profitable? Company Net Margins Return on Equity Return on Assets Atlantic Coastal Acquisition Corp. IIN/A N/A N/A Biofrontera N/A N/A N/A Does the media prefer ACABW or BFRIW? In the previous week, Biofrontera had 1 more articles in the media than Atlantic Coastal Acquisition Corp. II. MarketBeat recorded 1 mentions for Biofrontera and 0 mentions for Atlantic Coastal Acquisition Corp. II. Atlantic Coastal Acquisition Corp. II's average media sentiment score of 0.00 equaled Biofrontera'saverage media sentiment score. Company Overall Sentiment Atlantic Coastal Acquisition Corp. II Neutral Biofrontera Neutral Which has better valuation and earnings, ACABW or BFRIW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAtlantic Coastal Acquisition Corp. IIN/AN/AN/AN/AN/ABiofrontera$43.20MN/AN/AN/AN/A SummaryBiofrontera beats Atlantic Coastal Acquisition Corp. II on 2 of the 2 factors compared between the two stocks.How does Atlantic Coastal Acquisition Corp. II compare to Celularity?Atlantic Coastal Acquisition Corp. II (NASDAQ:ACABW) and Celularity (NASDAQ:CELUW) are both pharmaceutical products companies, but which is the superior stock? We will contrast the two businesses based on the strength of their media sentiment, dividends, institutional ownership, profitability, risk, earnings, analyst recommendations and valuation. Is ACABW or CELUW more profitable? Company Net Margins Return on Equity Return on Assets Atlantic Coastal Acquisition Corp. IIN/A N/A N/A Celularity N/A N/A N/A Does the media prefer ACABW or CELUW? In the previous week, Atlantic Coastal Acquisition Corp. II's average media sentiment score of 0.00 equaled Celularity'saverage media sentiment score. Company Overall Sentiment Atlantic Coastal Acquisition Corp. II Neutral Celularity Neutral Which has preferable earnings & valuation, ACABW or CELUW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAtlantic Coastal Acquisition Corp. IIN/AN/AN/AN/AN/ACelularity$26.55MN/AN/AN/AN/A SummaryCelularity beats Atlantic Coastal Acquisition Corp. II on 1 of the 1 factors compared between the two stocks. Get Atlantic Coastal Acquisition Corp. II News Delivered to You Automatically Sign up to receive the latest news and ratings for ACABW and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ACABW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ACABW vs. The Competition ExportMetricAtlantic Coastal Acquisition Corp. IIShell Companies IndustryFinancial SectorNASDAQ ExchangeMarket CapN/A$84.54M$5.86B$12.34BDividend YieldN/A5.35%5.22%5.28%P/E RatioN/A0.9415.4722.89Price / SalesN/A1,161.27982.3686.28Price / CashN/A164.5292.8156.67Price / BookN/A42.176.577.14Net IncomeN/A-$131.69M$1.14B$335.98M7 Day PerformanceN/A0.33%0.78%3.56%1 Month PerformanceN/A1.96%1.89%2.54%1 Year PerformanceN/A13.42%19.90%35.05% Atlantic Coastal Acquisition Corp. II Competitors List ExportCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ACABWAtlantic Coastal Acquisition Corp. IIN/A$0.00flatN/A-77.3%$0.00N/AN/A15AIMDWAinosN/A$0.06-13.3%N/A-71.2%$0.00$18.11KN/A40Positive NewsGap UpALVOWAlvotechN/A$0.19-5.1%N/A-89.5%$0.00$586.32MN/A4Positive NewsGap UpARAVAraviveN/A$0.04flatN/AN/A$0.00N/AN/A20High Trading VolumeBFRIWBiofronteraN/A$0.02-27.3%N/A-75.5%$0.00$43.20MN/A70Gap Down Related Companies and Tools Related Companies Ainos Competitors Alvotech Competitors Aravive Competitors Biofrontera Competitors Celularity Competitors Cingulate Competitors Comera Life Sciences Competitors Dermata Therapeutics Competitors enGene Competitors Fortress Biotech Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ACABW) was last updated on 5/25/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | SponsoredSpaceX will mint billionaires. You won't be one of them.By the time a company goes public, 95% of profits have already been made. Insiders bought SpaceX at $20 billio...Behind the Markets | SponsoredSatellite Images Spot Potential $10 Trillion Discovery'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...Altimetry | SponsoredHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Atlantic Coastal Acquisition Corp. II Please log in to your account or sign up in order to add this asset to your watchlist. Share Atlantic Coastal Acquisition Corp. II With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
